FADS1 and colorectal carcinoma: The FADS1 enzyme has been shown to induce the enrichment of Gram-negative bacteria through a high arachidonic acid microenvironment, activate the conversion of the TLR4/MYD88 pathway to PGE2, and ultimately promote CRC tumorigenesis [53].